Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

FDA approves Yeztugo

The Washington Post on MSN · 1d
Here’s what everyone should know about this new HIV prevention shot
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
ConsumerAffairs · 2d
FDA approves twice-yearly injection for HIV prevention
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Pa
CBS News on MSN · 4d
HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained HIV negative.
1don MSN
FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection
He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...
NBC News4d
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months. Called Yeztugo, the highly effective drug has inspired feverish anticipation among ...
Rolling Out
3d
99.9% breakthrough transforms HIV prevention forever
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy